Cargando…
Inhibition of glutamate-carboxypeptidase-II in dorsolateral prefrontal cortex: potential therapeutic target for neuroinflammatory cognitive disorders
Glutamate carboxypeptidase-II (GCPII) expression in brain is increased by inflammation, e.g. by COVID19 infection, where it reduces NAAG stimulation of metabotropic glutamate receptor type 3 (mGluR3). GCPII-mGluR3 signaling is increasingly linked to higher cognition, as genetic alterations that weak...
Autores principales: | Yang, Shengtao, Datta, Dibyadeep, Elizabeth Woo, Duque, Alvaro, Morozov, Yury M., Arellano, Jon, Slusher, Barbara S., Wang, Min, Arnsten, Amy F. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718677/ https://www.ncbi.nlm.nih.gov/pubmed/35732693 http://dx.doi.org/10.1038/s41380-022-01656-x |
Ejemplares similares
-
Glutamate Carboxypeptidase II in Aging Rat Prefrontal Cortex Impairs Working Memory Performance
por: Datta, Dibyadeep, et al.
Publicado: (2021) -
Chronic GCPII (glutamate‐carboxypeptidase‐II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques
por: Bathla, Shveta, et al.
Publicado: (2023) -
The genie in the bottle-magnified calcium signaling in dorsolateral prefrontal cortex
por: Arnsten, Amy F. T., et al.
Publicado: (2020) -
Classical complement cascade initiating C1q protein within neurons in the aged rhesus macaque dorsolateral prefrontal cortex
por: Datta, Dibyadeep, et al.
Publicado: (2020) -
Glutamate Metabotropic Receptor Type 3 (mGlu3) Localization in the Rat Prelimbic Medial Prefrontal Cortex
por: Woo, Elizabeth, et al.
Publicado: (2022)